CapsoVision CV
NASDAQ CV
$6.02 +0.11 (+1.86%)
At close: Aug 21, 2026 · 4:00 PM EDT

CapsoVision (CV) Change in Accured Expenses (2024 - 2025)

CapsoVision (CV) posted Change in Accured Expenses of -$92000.0 for Q4 2025, down 107.66% sequentially from $1.2 million in Q3 2025, and up 86.57% YoY from -$49311.4 in Q4 2024.

CapsoVision (CV) Change in Accured Expenses (2024 - 2025) Analysis & Trends

CapsoVision has reported Change in Accured Expenses for 2 years, with the latest figure at -$92000.0 in Q4 2025.

  • Quarterly Change in Accured Expenses rose 86.57% year-over-year to -$92000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$404000.0 (changed N/A YoY) and the FY2025 annual result came in at $2.1 million, up 1143.14% from the prior year.
  • Change in Accured Expenses declined to -$92000.0 in Q4 2025 per CV's latest filing, from $1.2 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $1.2 million in Q3 2025 and troughed at -$828000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 298.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 123.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 234.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 123.70 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 112.90 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 19.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 43.01 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 4.80 Mn
10 CapsoVision 299.87 Mn 290.80 Mn 1.87 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -92,000.00
Dec 31, 2025 -92,000.00
Sep 30, 2025 1.20 Mn
Sep 30, 2025 1.20 Mn
Dec 31, 2024 -685,000.00
Dec 31, 2024 -685,000.00
Sep 30, 2024 -828,000.00
Sep 30, 2024 -828,000.00